NASDAQ

VanEck Pharmaceutical ETF (PPH)

303 Thanks from members

The VanEck Pharmaceutical ETF (PPH) presents a medium-risk profile with concentrated global pharmaceutical exposure, delivering strong trailing returns though tempered by high single-stock weightings like Eli Lilly and ongoing drug pricing policy risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →